NO20021527D0 - Pyrimidinderivater, fremgangsmåte for fremstilling av derivatene og legemidler inneholdende de samme som den aktivebestanddel - Google Patents

Pyrimidinderivater, fremgangsmåte for fremstilling av derivatene og legemidler inneholdende de samme som den aktivebestanddel

Info

Publication number
NO20021527D0
NO20021527D0 NO20021527A NO20021527A NO20021527D0 NO 20021527 D0 NO20021527 D0 NO 20021527D0 NO 20021527 A NO20021527 A NO 20021527A NO 20021527 A NO20021527 A NO 20021527A NO 20021527 D0 NO20021527 D0 NO 20021527D0
Authority
NO
Norway
Prior art keywords
derivatives
preparation
active ingredient
same
drugs containing
Prior art date
Application number
NO20021527A
Other languages
English (en)
Other versions
NO20021527L (no
Inventor
Tsutomu Kojima
Takanori Okada
Katsutoshi Hachiya
Takahiro Motoi
Shinsuke Hashimoto
Original Assignee
Ono Pharmaceutical Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ono Pharmaceutical Co filed Critical Ono Pharmaceutical Co
Publication of NO20021527D0 publication Critical patent/NO20021527D0/no
Publication of NO20021527L publication Critical patent/NO20021527L/no

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D239/00Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/02Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
    • C07D239/24Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
    • C07D239/28Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
    • C07D239/32One oxygen, sulfur or nitrogen atom
    • C07D239/34One oxygen atom
    • C07D239/36One oxygen atom as doubly bound oxygen atom or as unsubstituted hydroxy radical
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/02Stomatological preparations, e.g. drugs for caries, aphtae, periodontitis
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00Drugs for disorders of the respiratory system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D405/00Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/06Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D413/00Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/02Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
    • C07D413/12Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Public Health (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Pulmonology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
NO20021527A 1999-09-27 2002-03-26 Pyrimidinderivater, fremgangsmåte for fremstilling av derivatene og legemidler inneholdende de samme som den aktivebestanddel NO20021527L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP27184399 1999-09-27
PCT/JP2000/006601 WO2001023361A1 (fr) 1999-09-27 2000-09-26 Derives de la pyrimidine, leur procede de preparation, et medicaments les contenant comme principe actif

Publications (2)

Publication Number Publication Date
NO20021527D0 true NO20021527D0 (no) 2002-03-26
NO20021527L NO20021527L (no) 2002-05-27

Family

ID=17505658

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20021527A NO20021527L (no) 1999-09-27 2002-03-26 Pyrimidinderivater, fremgangsmåte for fremstilling av derivatene og legemidler inneholdende de samme som den aktivebestanddel

Country Status (12)

Country Link
EP (1) EP1219608A4 (no)
KR (1) KR20020028232A (no)
CN (1) CN1399632A (no)
AU (1) AU7444600A (no)
BR (1) BR0014319A (no)
CA (1) CA2385292A1 (no)
HU (1) HUP0203835A3 (no)
MX (1) MXPA02003186A (no)
NO (1) NO20021527L (no)
NZ (1) NZ517962A (no)
WO (1) WO2001023361A1 (no)
ZA (1) ZA200202426B (no)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2001277736A1 (en) * 2000-08-10 2002-02-25 Ono Pharmaceutical Co. Ltd. 2-(5-amino-6-oxo-2-phenyl-1,6-dihydro-1-pyrimidyl)-n-(1-(2-( -t-butyl-1,3,4-oxadiazolyl)carbonyl)-2-(r,s)-methylpropyl) acetamide hydrochloride
EP1318150A4 (en) * 2000-09-08 2004-04-14 Ono Pharmaceutical Co NEW CRYSTALS OF 1,3,4-OXADIAZOLE DERIVATIVES, METHOD FOR THE PRODUCTION OF THE CRYSTALS AND THE MEDICINAL PRODUCTS CONTAINING THEM AS AN ACTIVE SUBSTANCE
IL148924A (en) * 2002-03-26 2015-06-30 Mor Research Applic Ltd Use of substances that inhibit intracellular elastase activity in the preparation of a drug for the treatment and / or prevention of necrosis of cells and related diseases

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9216272D0 (en) * 1991-08-15 1992-09-09 Ici Plc Substituted heterocycles
CN1247542A (zh) * 1996-12-06 2000-03-15 康泰驰公司 丝氨酸蛋白酶抑制剂
ZA9810490B (en) * 1997-12-03 1999-05-20 Dainippon Pharmaceutical Co 2-Aryl-8-oxodihydropurine derivative process for the preparation thereof pharmaceutical composition containing the same and intermediate therefor

Also Published As

Publication number Publication date
KR20020028232A (ko) 2002-04-16
NZ517962A (en) 2003-11-28
WO2001023361A1 (fr) 2001-04-05
HUP0203835A3 (en) 2003-07-28
MXPA02003186A (es) 2002-10-31
HUP0203835A2 (en) 2003-05-28
EP1219608A4 (en) 2003-01-08
BR0014319A (pt) 2002-07-16
AU7444600A (en) 2001-04-30
ZA200202426B (en) 2003-08-19
NO20021527L (no) 2002-05-27
EP1219608A1 (en) 2002-07-03
CA2385292A1 (en) 2001-04-05
CN1399632A (zh) 2003-02-26

Similar Documents

Publication Publication Date Title
LTC1345910I2 (lt) Chinazolidino dariniai, minėtus junginius turintys vaistai, jų panaudojimas ir jų gavimo būdas
HUP0204170A3 (en) 5-thia-omega-substituted phenyl-prostaglandin e derivatives, process for producing the same and drugs containing the same as the active ingredient
NO20014013D0 (no) 16-halogenepotilonderivater, fremgangsmater for fremstilling av dem og deres farmasoytiske anvendelse
NO20040268L (no) Nye 2H-pyridazin-3-derivater, farmasoytiske preparater inneholdende slike og fremgangsmate for fremstilling av den aktive ingrediensen
NO20021689L (no) 5-leddede heterocykliske derivater, fremstilling derav og anvendelse som medikamenter
DK1202965T3 (da) Indolderivater, fremgangsmåde til fremstilling deraf, farmaceutiske præparater indeholdende disse og deres medicinske anvendelse
AU7962200A (en) Novel indole derivatives and drugs containing the same as the active ingredient
HUP0200309A3 (en) Arylpiperazinyl-cyclohexyl indole derivatives for the treatment of depression, process for their preparation and pharmaceutical compositions containing them
HUP0204226A3 (en) Quinazoline derivatives, pharmaceutical compositions containing them, their use and process for the preparation of the compounds
HUP0203312A3 (en) Pharmaceutically active sulfonamide derivatives, process for their preparation, and pharmaceutical compositions and their use
DK1557415T3 (da) Heterocykliske forbindelser og antitumorlægemidler indeholdende samme som den aktive ingrediens
HK1074163A1 (en) Derivatives of tryptamine and analogous compounds, and pharmaceutical formulations containing them
HUP0203385A3 (en) Pyrimidine derivatives, process for their preparation, pharmaceutical compositions containing them and their use
NO20022021D0 (no) Indeno-, nafto- og benzocyklohepta-dihydrotiazolderivater, fremstilling av de samme og deres anvendelse somanoreksilegemidler
HUP0600084A2 (en) Pharmaceutical compositions containing ascorbic acid derivatives, methods of production of the active ingredient
NO20021527L (no) Pyrimidinderivater, fremgangsmåte for fremstilling av derivatene og legemidler inneholdende de samme som den aktivebestanddel
NO20042022L (no) Fast legemiddelformulering som inneholder pipiperazinurea-derivat og fremgangsmate for fremstilling av formuleringen
EE05401B1 (et) Imidasolidiini derivaadid, nende valmistamine ja kasutamine p?letikuvastaste toimeainetena ning neid sisaldav ravimpreparaat
HUP0200993A3 (en) Thio-oxindole derivatives, use of them for producing pharmaceutical compositions and pharmaceutical compositions containing them
HUP0203650A3 (en) Heterocyclic derivatives, process for their preparation, pharmaceutical compositions containing them and their use
AU1556601A (en) 1,3,4-oxadiazolin-2-one derivatives and drugs containing these derivatives as the active ingredient
NO20041878D0 (no) Karboksylsyrederivat-forbindelser og legemidler inneholdende de samme som den aktive bestanddel.
PL352041A1 (en) Derivatives of isochynoline, pharmaceutical compositions containing these derivatives and method of obtaining an active substance
EE200100592A (et) 14ß-H-steroolid, neid sisaldavad farmatseutilisedkompositsioonid ja nende derivaatide kasutamine meioosi reguleerivate ravimite valmistamiseks
DK1236726T3 (da) Triazaspiro[5.5]undecan-derivater og lægemidler indeholdende samme som den aktive bestanddel